Association Between Complement Factor H and Proteoglycans in Early Human Coronary Atherosclerotic Lesions
- 1 April 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (4) , 630-636
- https://doi.org/10.1161/01.atv.0000057808.91263.a4
Abstract
Objective—Complement activation has been suggested to play a role in atherogenesis. To study the regulation of complement activation in human coronary atherosclerotic lesions, we examined the spatial relationships between the major complement inhibitor, factor H, and the complement activation products C3d and C5b-9.Methods and Results—In early lesions (American Heart Association types II and III), factor H was immunohistochemically found in the superficial proteoglycan-rich layer in association with numerous macrophages and C3d, whereas C5b-9 was found deeper in the intima, where factor H was virtually absent. In vitro experiments involving surface plasmon resonance and affinity chromatography analyses demonstrated that isolated human arterial proteoglycans bind factor H, and functional complement assays showed that glycosaminoglycans inhibit the complement activation induced by modified low density lipoprotein or by a foreign surface.Conclusions—The present observations raise the possibility that proteoglycans, because of their ability to bind the major complement inhibitor factor H, may inhibit complement activation in the superficial layer of the arterial intima. In contrast, deeper in the intima, where factor H and proteoglycans are absent, complement may be activated and proceed to C5b-9. Thus, the superficial and the deep layers of the human coronary artery appear to differ in their ability to regulate complement activation.Keywords
This publication has 29 references indexed in Scilit:
- Generation of C-Reactive Protein and Complement Components in Atherosclerotic PlaquesPublished by Elsevier ,2001
- Complement Activation after Oxidative StressThe American Journal of Pathology, 2000
- In situ complement activation in porcine membranoproliferative glomerulonephritis type IIKidney International, 1998
- Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti‐factor H antibodies: evidence for multiple interactions between H and surface bound C3bFEBS Letters, 1996
- CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesionsAtherosclerosis, 1992
- Complement receptors and regulatory proteins in human atherosclerotic lesions.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.Journal of Clinical Investigation, 1989
- Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position☆Molecular Immunology, 1987
- Immunoglobulins and complement components in human aortic atherosclerotic intimaAtherosclerosis, 1985
- Soluble proteins in the human atheroschlerotic plaqueAtherosclerosis, 1979